[ CAS No. 1446817-84-0 ]

Name: 1446817-84-0|1,1,1,3,3,3-Hexafluoropropan-2-yl 4-(2-(pyrrolidin-1-yl)-4-(trifluoromethyl)benzyl)piperazine-1-carboxylate|98%
Brand: Ambeed
SKU: A866363
Price: 13.0 USD
Availability: InStock
Rating: 94 (35 reviews)

{[proInfo.proName]} ,{[proInfo.pro_purity]}

Cat. No.: {[proInfo.prAm]}

2D 3D

Structure of 1446817-84-0 * Storage: {[proInfo.prStorage]}

Cart0 Add to My Favorites Bulk Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

For Research Only 88K+ Compounds Competitive Price 1-2 Day Shipping

Quality Control of [ 1446817-84-0 ]

COA NMR CNMR HPLC LC-MS

Related Doc. of [ 1446817-84-0 ]

SDS

Alternatived Products of [ 1446817-84-0 ]

Product Details of [ 1446817-84-0 ]

CAS No. :	1446817-84-0	MDL No. :	MFCD31735112
Formula :	C₂₀H₂₂F₉N₃O₂	Boiling Point :	-
Linear Structure Formula :	-	InChI Key :	N/A
M.W :	507.39 g/mol	Pubchem ID :	71657619
Synonyms :	1. ABX-1431

Calculated chemistry of of [ 1446817-84-0 ]

Physicochemical Properties

Num. heavy atoms :	34
Num. arom. heavy atoms :	6
Fraction Csp3 :	0.65
Num. rotatable bonds :	9
Num. H-bond acceptors :	12.0
Num. H-bond donors :	0.0
Molar Refractivity :	113.07
TPSA :	36.02 Å²

Pharmacokinetics

GI absorption :	Low
BBB permeant :	No
P-gp substrate :	No
CYP1A2 inhibitor :	No
CYP2C19 inhibitor :	Yes
CYP2C9 inhibitor :	Yes
CYP2D6 inhibitor :	Yes
CYP3A4 inhibitor :	Yes
Log Kp (skin permeation) :	-5.69 cm/s

Lipophilicity

Log Po/w (iLOGP) :	4.11
Log Po/w (XLOGP3) :	5.22
Log Po/w (WLOGP) :	7.43
Log Po/w (MLOGP) :	3.8
Log Po/w (SILICOS-IT) :	4.45
Consensus Log Po/w :	5.0

Druglikeness

Lipinski :	1.0
Ghose :	None
Veber :	0.0
Egan :	1.0
Muegge :	2.0
Bioavailability Score :	0.55

Water Solubility

Log S (ESOL) :	-5.81
Solubility :	0.000784 mg/ml ; 0.00000155 mol/l
Class :	Moderately soluble
Log S (Ali) :	-5.72
Solubility :	0.000957 mg/ml ; 0.00000189 mol/l
Class :	Moderately soluble
Log S (SILICOS-IT) :	-5.24
Solubility :	0.00293 mg/ml ; 0.00000577 mol/l
Class :	Moderately soluble

Medicinal Chemistry

PAINS :	0.0 alert
Brenk :	0.0 alert
Leadlikeness :	3.0
Synthetic accessibility :	3.11

Safety of [ 1446817-84-0 ]

Signal Word:	Warning	Class:	N/A
Precautionary Statements:	P261-P305+P351+P338	UN#:	N/A
Hazard Statements:	H302-H315-H319-H335	Packing Group:	N/A
GHS Pictogram:

Application In Synthesis of [ 1446817-84-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

Downstream synthetic route of [ 1446817-84-0 ]

[ 1446817-84-0 ] Synthesis Path-Downstream 1~11

Yield	Reaction Conditions	Operation in experiment
	Stage #1: With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 2h; Stage #2: In dichloromethane at 20℃; for 2h;	82.4 Step 4: l,l,l_?3,3,3-hexafluoropropan-2-yl 4-[[2-(morpholin-4-yl)-3- (trifluoromethyl)phenyl]methyl]piperazine-l-carboxylate General procedure: A 50 mL round-bottom flask was charged with l, l, l,3,3,3-hexafluoropropan-2- ol (168 mg, 1.00 mmol, 1.10 equiv), triphosgene (99.0 mg, 0.330 mmol, 0.33 equiv), dichloromethane (10 mL). N,N-Diisopropylethylamine (381 mg, 2.95 mmol, 3.24 equiv) was added dropwise. The mixture was stirred at room temperature for 2 h. 4-[2-(Piperazin-l- ylmethyl)-5-(trifluoromethyl)phenyl]morpholine (300 mg, 0.910 mmol, 1.00 equiv) was added. The resulting solution was stirred for 2 hours at room temperature and diluted with dichloromethane (20 mL). The resulting mixture was washed with H20 (2 x 10 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was chromatographed on a silica gel column with ethyl acetate/petroleum ether (1/3). Thecrude product (337 mg) was purified by preparative HPLC using the following gradient conditions: 20% CH3CN/80% phase A increasing to 80% CH3CN over 10 min, then to 100% CH3CN over 0.1 min, holding at 100% CH3CN for 1.9 min, then reducing to 20% over 0.1 min, and holding at 20% for 1.9 min, on a waters 2767-5 chromatograph. Column: X-bridge Prep Ci8, 19* 150mm 5um; Mobile phase: Phase A: aqueous NH4HCO3(0.05%); Phase B: CH3CN; Detector, UV220 & 254nm. Purification resulted in 171.9 mg (35% yield) of 1, 1,1,3,3,3- hexafluoropropan-2-yl 4-[[2-(morpholin-4-yl)-3-(trifluoromethyl)phenyl]methyl]piperazine-l- carboxylate as light yellow oil. XH NMR 300 MHz (CDC13) δ 7.54-7.623 (m, 1H), 7.33-7.42 (m, 2H), 5.72-5.85 (m, 1H), 3.84-3.87 (m, 4H), 3.64 (s, 2H), 3.56-3.57 (m, 4H), 2.96-3.00 (m, 4H), 2.51-2.52 (m, 4H). LCMS (ESI, m/z): 524 [M+H]+.

2
[ 1446817-84-0 ]
1,1,1,3,3,3-hexafluoropropan-2-yl 4-(2-(pyrrolidin-1-yl)-4-(trifluoromethyl)benzyl)piperazine-1-carboxylate mono-hydrochloride [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
91.4%	With hydrogenchloride In water; isopropyl alcohol at 38 - 42℃; Large scale;	12.d; 13.d Example 12: Formation of Compound I-HCl Form 2 Step d): Compound I (16.29 kg) was charged in a vessel followed by isopropanol (84.3 kg) and stirred at 38-40° C. for approx. 20 minutes. Solution was filtered in a second vessel and isopropanol (2.4 kg) was used as rinse from first to second vessel; temperature was maintained in the range 38-42° C. Approx. 6M HCl in isopropanol (1.1 kg) was added over approx. 15 minutes under stirring maintaining the temperature in the range 38-42° C. Seed (30 g) of Compound I-HCl form 2 was added followed by a second portion of 6M HCl in isopropanol (2.7 kg in approx. 15 minutes. The suspension was stirred at 38-42° C. for approx. 35 minutes. A third portion of 6M HCl in isopropanol (0.8 kg was added in approx. 15 minutes and the suspension was stirred for further approx. 70 minutes at 38-42° C., then cooled in approx. 60 minutes to 30° C., stirred for approx. 90 minutes, cooled to 20° C. in approx. 60 minutes and stirred at this temperature for up to 13 hours. Solid was isolated and washed with isopropanol (2×16 kg) and the wet solid was air dried at 35-40° C. for approx. 9 hours to end up with the desired product Compound I-HCl form 2 (15.96 kg, 91.4%). 1H-NMR (DMSO-d6): δ(ppm) 1.90-1.93 (4H, t), 3.22-3.25 (8H, t), 3.82 (4H, bs), 4.49 (2H, bs), 6.60-6.67 (1H, m), 7.24-7.25 (2H, m), 7.92-7.94 (1H, d), 11.40 (1H, bs).
90%	With hydrogenchloride In tert-butyl methyl ether; water at 35℃;	2 Example 2. Preparation of Compound 2 (Form 1) jjmono-HC111 To Compound 1 (20.0 g) in 9 v/w of tert-butylmethyl ether was added conc. HC1 (1.06 eq) at 3 5°C. The suspension was cooled to room temperature and the solid was collected by filtration and washed with tert-butylmethyl ether. The solid was dried to give Compound 2 (19.3 g, 90%).

Reference： [1]Current Patent Assignee: H. LUNDBECK A/S - US2021/323938, 2021, A1 Location in patent: Paragraph 0303-0305
[2]Current Patent Assignee: H. LUNDBECK A/S - WO2018/93953, 2018, A1 Location in patent: Paragraph 00366

3
[ 75-75-2 ]
[ 1446817-84-0 ]
C₂₀H₂₂F₉N₃O₂*CH₄O₃S [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
85.3%	In tert-butyl methyl ether at 40℃; for 1.25h;	Mesylate salt (Compound 5) j00513J 300 mg of Compound 1 were weighed into a 20 mL glass scintillation vial. The solid was fully dissolved in tert-butylmethyl ether (6.0 mL) at 40°C. 1.0 equivalent of neat methane sulfonic acid (38.4 1iL) was added to the free base solution. Precipitation was observed within minutes from the addition. The mixture was stirred at 40°C for 1 hour following by cooling to room temperature. The resulting solid was isolated by centrifugation (Crop 1) and the remaining slurry from the vial was left to slowly evaporate. This yielded more solid (Crop 2). Both crops were dried in a desiccator for 3 hours and analyzed separately by XRPD and HPLC. According to XRPD analysis, Crop 1 and 2 both corresponded to the same form and had similar levels of crystallinity. Moreover, XRPD analysis confirmed that the mesylate salt obtained from the secondary screen corresponded to the form obtained in the primary screen. The combined crop yield was 8 5.3%. Crop 1 was used for the full characterization of the salt.

Reference： [1]Current Patent Assignee: H. LUNDBECK A/S - WO2018/93953, 2018, A1 Location in patent: Paragraph 00513

4
[ 1446817-84-0 ]
[ 110-17-8 ]
(x)C₄H₄O₄*C₂₀H₂₂F₉N₃O₂ [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
	In ethanol; acetonitrile at 40℃; for 1h;	Fumarate salt (Compound 6), Form 1 j00520J 300 mg of Compound 1 were weighed into a 20 mL glass scintillation vial. The solid was fully dissolved in MeCN (1.5 mL) at 40°C. 1.05 equivalents of fumaric acid (72.06 mg) were weighed out in a different vial and the solid was fully dissolved in EtOH (2.4 mL) at 40°C. The fumaric acid solution was added to the free base solution and the mixture was stirred at 40°C for 1 hour. The mixture was cooled to room temperature and the solution was subjected to slow evaporation for 2 days. Afterwards, the vial was stored at 5°C for a further 3 days to aid precipitation. The resulting solid was isolated by centrifugation (Crop 1) and the resulting mother liquor was left to slowly evaporate. This yielded more solid (Crop 2). Both crops were dried in a desiccator for 3 hours and analyzed by XRPD and HPLC.

Reference： [1]Current Patent Assignee: H. LUNDBECK A/S - WO2018/93953, 2018, A1 Location in patent: Paragraph 00520

5
[ 89763-93-9 ]
[ 1446817-84-0 ]

Reference： [1]Journal of Medicinal Chemistry,2018,vol. 61,p. 9062 - 9084

6
[ 1374603-97-0 ]
[ 1446817-84-0 ]

Yield	Reaction Conditions	Operation in experiment
	Multi-step reaction with 3 steps 1.1: 0.5 h / 20 °C / Inert atmosphere 1.2: 20 °C / Inert atmosphere 2.1: trifluoroacetic acid / dichloromethane / 18 h / 0 - 20 °C / Inert atmosphere 3.1: N-ethyl-N,N-diisopropylamine / dichloromethane / 2 h / 20 °C / Inert atmosphere 3.2: 2 h / 20 °C / Inert atmosphere

Reference： [1]Cisar, Justin S.; Weber, Olivia D.; Clapper, Jason R.; Blankman, Jacqueline L.; Henry, Cassandra L.; Simon, Gabriel M.; Alexander, Jessica P.; Jones, Todd K.; Ezekowitz, R. Alan B.; O'Neill, Gary P.; Grice, Cheryl A. [Journal of Medicinal Chemistry, 2018, vol. 61, # 20, p. 9062 - 9084]

7
[ 1446819-16-4 ]
[ 1446817-84-0 ]

Yield	Reaction Conditions	Operation in experiment
	Multi-step reaction with 2 steps 1.1: trifluoroacetic acid / dichloromethane / 18 h / 0 - 20 °C / Inert atmosphere 2.1: N-ethyl-N,N-diisopropylamine / dichloromethane / 2 h / 20 °C / Inert atmosphere 2.2: 2 h / 20 °C / Inert atmosphere

8
[ 32315-10-9 ]
[ 920-66-1 ]
[ 1446819-17-5 ]
[ 1446817-84-0 ]

Yield	Reaction Conditions	Operation in experiment
79%	Stage #1: bis(trichloromethyl) carbonate; 1,1,1,3',3',3'-hexafluoro-propanol With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃; for 2h; Inert atmosphere; Stage #2: 1-[[2-(pyrrolidin-1-yl)-4-(trifluoromethyl)phenyl]methyl]piperazine In dichloromethane at 20℃; for 2h; Inert atmosphere;

9
[ 1374603-97-0 ]
1,1,1,3,3,3-hexafluoropropan-2-yl piperazine-1-carboxylate, 2,2,2-trifluoroacetate salt [ No CAS ]
[ 1446817-84-0 ]

Yield	Reaction Conditions	Operation in experiment
92%	Stage #1: 1,1,1,3,3,3-hexafluoropropan-2-yl piperazine-1-carboxylate, 2,2,2-trifluoroacetate salt With triethylamine In ethyl acetate at 20 - 25℃; for 1.25h; Large scale; Stage #2: 2-(pyrrolidin-1-yl)-4-(trifluoromethyl)benzaldehyde In ethyl acetate at 20 - 25℃; for 3.25h; Inert atmosphere; Large scale; Stage #3: With sodium tris(acetoxy)borohydride In ethyl acetate at 20 - 25℃; Inert atmosphere; Large scale;	9.c Example 9: Synthesis of Compound I Via TFA Route Step c) via TFA route: A3-TFA (16.2 kg) was charged in a vessel at 20-25° C. followed by EtOAc (57 kg) at 20-25° C. obtaining a suspension. TEA (4.4 kg) was added over 15 min and the mixture was stirred at 20-25° C. for 1 hour. The A5 solution obtained in example 5 (20.5 kg) was added under nitrogen over 15 min at 20-25° C. and the mixture was stirred at 20-25° C. for 3 hours. STAB (9.8 kg) was added in 4 equal portions, waiting about 30 minutes between every portion and the following one while maintaining the temperature between 20 and 25° C. Subsequently, the suspension was stirred for 12 hours, followed by the addition of a further portion of STAB (1.4 kg) and a further stirring period of 2 hours. Subsequently, a further portion of STAB (0.3 kg) was added to the suspension followed by stirring for 2 hours. Purified water (13.5 kg) was added at 20° C. over 2 hours to form a phase separation. The organic phase was diluted with EtOAc (12.3 kg) and washed with purified water (63.2 kg). The organic phase was concentrated under vacuum below 40° C. to approx. 25 l. Methanol (21.4 kg) was added and solution was concentrated under vacuum to approx. 25 l. Methanol (48.2 kg) was added and the solution heated to 48-52° C. Purified water (81.2 kg) was slowly added in approx. 2 hours obtaining a suspension that was stirred at 48-52° C. for 30 minutes, followed by cooling to 20° C. over 3 hours and stirred at 20° C. for 3 hours. Suspension was centrifugated and washed with purified water/methanol mixture (27.1 kg/47.6 kg), the wet solid (18.49 kg) was dried under nitrogen flow for no less than 8 hours in a static drier affording Compound 1 (17.29 kg, 92% yield). 1H-NMR (DMSO-d6): δ(ppm) 1.86-1.89 (4H, t), 2.39 (4H, m), 3.24-3.27 (4H, t), 3.56 (2H, s), 6.53-6.63 (1H, m), 7.01-7.02 (1H, d), 7.09-7.11 (1H, dd), 7.53-7.55 (1H, d).

Reference： [1]Current Patent Assignee: H. LUNDBECK A/S - US2021/323938, 2021, A1 Location in patent: Paragraph 0295-0297

10
[ 1374603-97-0 ]
1,1,1,3,3,3-hexafluoropropan-2-yl piperazine-1-carboxylate hydrochloride [ No CAS ]
[ 1446817-84-0 ]

Yield	Reaction Conditions	Operation in experiment
92%	Stage #1: 1,1,1,3,3,3-hexafluoropropan-2-yl piperazine-1-carboxylate hydrochloride With triethylamine In ethyl acetate at 20 - 25℃; for 1.25h; Large scale; Stage #2: 2-(pyrrolidin-1-yl)-4-(trifluoromethyl)benzaldehyde In ethyl acetate at 20 - 25℃; for 3h; Inert atmosphere; Large scale; Stage #3: With sodium tris(acetoxy)borohydride In ethyl acetate at 20 - 25℃; for 15.5h; Inert atmosphere; Large scale;	10.c; 11.c Example 10: Synthesis of Compound I Via HCl Route Step c) via HCl route: A3-HCl (12.9 kg, 1.43 wt. %) was charged in vessel at 20-25° C. followed by EtOAc (57 kg) at 20-25° C. obtaining a suspension. TEA (4.4 kg) was added over 15 min and the mixture was stirred at 20-25° C. for 1 hour. Water (102 g) was added to the A5 solution from example 4 (20.5 kg at 44% w/w). The A5 solution was then added under nitrogen over 15 min at 20-25° C. and the mixture was stirred at 20-25° C. for 3 hours. STAB (9.8 kg) was added in 4 equal portions waiting about 30 minutes between every portion and the following one while maintaining the temperature between 20-25° C. The suspension was stirred for 15 hours. Purified water (13.5 kg) was added at 20° C. over 2 hours to obtain a phase separation. The organic phase was diluted with EtOAc (12.3 kg) and washed with purified water (63.2 kg). The organic phase was concentrated under vacuum below 40° C. to approx. 25 l. Methanol (21.4 kg) was added and solution was concentrated again under vacuum to approx. (25 l). Methanol (48.2 kg) was added and the solution was heated to 48-52° C. Purified water (81.2 kg) was slowly added over approx. 2 hours obtaining a suspension that was stirred at 48-52° C. for 30 minutes then cooled to 20° C. over 3 hours and stirred at 20° C. for approx. 3 hours. Suspension was centrifugated and washed with a purified water/methanol mixture (27.1 kg/47.6 kg). The wet solid (18.33 kg) was dried under nitrogen flow in a static drier for about 8 hours affording Compound 1 (17.33 kg, yield 92%). 1H-NMR (DMSO-d6): δ(ppm) 1.86-1.89 (4H, t), 2.39 (4H, m), 3.24-3.27 (4H, t), 3.56 (2H, s), 6.53-6.63 (1H, m), 7.01-7.02 (1H, d), 7.09-7.11 (1H, dd), 7.53-7.55 (1H, d).

Reference： [1]Current Patent Assignee: H. LUNDBECK A/S - US2021/323938, 2021, A1 Location in patent: Paragraph 0298-0302

11
[ 1446817-18-0 ]
[ 1446817-84-0 ]

Yield	Reaction Conditions	Operation in experiment
	Multi-step reaction with 2 steps 1.1: hydrogenchloride / water; Isopropyl acetate / 1 h / 15 - 23 °C / Large scale 2.1: triethylamine / ethyl acetate / 1.25 h / 20 - 25 °C / Large scale 2.2: 3 h / 20 - 25 °C / Inert atmosphere; Large scale 2.3: 15.5 h / 20 - 25 °C / Inert atmosphere; Large scale
	Multi-step reaction with 2 steps 1.1: 2 h / 25 °C / Large scale 2.1: triethylamine / ethyl acetate / 1.25 h / 20 - 25 °C / Large scale 2.2: 3.25 h / 20 - 25 °C / Inert atmosphere; Large scale 2.3: 20 - 25 °C / Inert atmosphere; Large scale

Reference： [1]Current Patent Assignee: H. LUNDBECK A/S - US2021/323938, 2021, A1
[2]Current Patent Assignee: H. LUNDBECK A/S - US2021/323938, 2021, A1

Related Products

Historical Records

Ghs Precautionary Statements

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Purity	Size	Price	VIP Price	USA Stock *0-1 Day	Global Stock *5-7 Days	Quantity
{[ item.p_purity ]}	{[ item.pr_size ]}	{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]}	{[ getRatePrice(item.pr_usd, 1,1) ]}	{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]}	{[ item.pr_usastock ]}	Inquiry -	{[ item.pr_chinastock ]}	Inquiry -

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed
H304	May be fatal if swallowed and enters airways
H305	May be harmful if swallowed and enters airways
H310	Fatal in contact with skin
H311	Toxic in contact with skin
H312	Harmful in contact with skin
H313	May be harmful in contact with skin
H314	Causes severe skin burns and eye damage
H315	Causes skin irritation
H316	Causes mild skin irritation
H317	May cause an allergic skin reaction
H318	Causes serious eye damage
H319	Causes serious eye irritation
H320	Causes eye irritation
H330	Fatal if inhaled
H331	Toxic if inhaled
H332	Harmful if inhaled
H333	May be harmful if inhaled
H334	May cause allergy or asthma symptoms or breathing difficulties if inhaled
H335	May cause respiratory irritation
H336	May cause drowsiness or dizziness
H340	May cause genetic defects
H341	Suspected of causing genetic defects
H350	May cause cancer
H351	Suspected of causing cancer
H360	May damage fertility or the unborn child
H361	Suspected of damaging fertility or the unborn child
H361d	Suspected of damaging the unborn child
H362	May cause harm to breast-fed children
H370	Causes damage to organs
H371	May cause damage to organs
H372	Causes damage to organs through prolonged or repeated exposure
H373	May cause damage to organs through prolonged or repeated exposure
Environmental hazards
Code	Phrase
H400	Very toxic to aquatic life
H401	Toxic to aquatic life
H402	Harmful to aquatic life
H410	Very toxic to aquatic life with long-lasting effects
H411	Toxic to aquatic life with long-lasting effects
H412	Harmful to aquatic life with long-lasting effects
H413	May cause long-lasting harmful effects to aquatic life
H420	Harms public health and the environment by destroying ozone in the upper atmosphere

[ CAS No. 1446817-84-0 ]

Quality Control of [ 1446817-84-0 ]

Related Doc. of [ 1446817-84-0 ]

Product Details of [ 1446817-84-0 ]

Calculated chemistry of of [ 1446817-84-0 ]

Physicochemical Properties

Pharmacokinetics

Lipophilicity

Druglikeness

Water Solubility

Medicinal Chemistry

Safety of [ 1446817-84-0 ]

Application In Synthesis of [ 1446817-84-0 ]

[ 1446817-84-0 ] Synthesis Path-Downstream 1~11

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry